相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Humanizing the zebrafish liver shifts drug metabolic profiles and improves pharmacokinetics of CYP3A4 substrates
Kar Lai Poon et al.
ARCHIVES OF TOXICOLOGY (2017)
Unraveling cellular pathways contributing to drug-induced liver injury by dynamical modeling
Isoude A. Kuijper et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2017)
Engineered Liver Platforms for Different Phases of Drug Development
Brenton R. Ware et al.
TRENDS IN BIOTECHNOLOGY (2017)
Minimizing the risk of chemically reactive metabolite formation of new drug candidates: implications for preclinical drug design
Andreas Brink et al.
DRUG DISCOVERY TODAY (2017)
WITHDRAWN-a resource for withdrawn and discontinued drugs
Vishal B. Siramshetty et al.
NUCLEIC ACIDS RESEARCH (2016)
Human hepatocytes derived from pluripotent stem cells: a promising cell model for drug hepatotoxicity screening
Maria Jose Gomez-Lechon et al.
ARCHIVES OF TOXICOLOGY (2016)
The HepaRG cell line, a superior in vitro model to L-02, HepG2 and hiHeps cell lines for assessing drug-induced liver injury
Yu Wu et al.
CELL BIOLOGY AND TOXICOLOGY (2016)
Reactive Metabolites: Current and Emerging Risk and Hazard Assessments
Richard A. Thompson et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2016)
Computational Models for Human and Animal Hepatotoxicity with a Global Application Scope
Denis Mulliner et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2016)
Evaluation of multiple mechanism-based toxicity endpoints in primary cultured human hepatocytes for the identification of drugs with clinical hepatotoxicity: Results from 152 marketed drugs with known liver injury profiles
Jie Zhang et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2016)
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans
Minjun Chen et al.
DRUG DISCOVERY TODAY (2016)
Biology-Inspired Microphysiological System Approaches to Solve the Prediction Dilemma of Substance Testing
Uwe Marx et al.
ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION (2016)
THE DILI-SIM INITIATIVE. INTEGRATED SYSTEMS PHARMACOLOGY MODELING TO EXPLAIN AND PREDICT DRUG HEPATOTOXICITY
P. Watkins
CLINICAL THERAPEUTICS (2015)
Development of novel tools for the in vitro investigation of drug-induced liver injury
Jian Jiang et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2015)
Are zebrafish larvae suitable for assessing the hepatotoxicity potential of drug candidates?
Natalie Mesens et al.
JOURNAL OF APPLIED TOXICOLOGY (2015)
Drug-induced liver injury: Interactions between drug properties and host factors
Minjun Chen et al.
JOURNAL OF HEPATOLOGY (2015)
Setting Clinical Exposure Levels of Concern for Drug-Induced Liver Injury (DILI) Using Mechanistic in vitro Assays
Falgun Shah et al.
TOXICOLOGICAL SCIENCES (2015)
Prediction of Drug-Induced Liver Injury in Micropatterned Co-cultures Containing iPSC-Derived Human Hepatocytes
Brenton R. Ware et al.
TOXICOLOGICAL SCIENCES (2015)
Minimizing DILI risk in drug discovery - A screening tool for drug candidates
S. Schadt et al.
TOXICOLOGY IN VITRO (2015)
The application of 3D cell models to support drug safety assessment: Opportunities & challenges
Adrian Roth et al.
ADVANCED DRUG DELIVERY REVIEWS (2014)
ACG Clinical Guideline: The Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury
Naga P. Chalasani et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
A testing strategy to predict risk for drug-induced liver injury in humans using high-content screen assays and the 'rule-of-two' model
Minjun Chen et al.
ARCHIVES OF TOXICOLOGY (2014)
High-Content Analysis in Toxicology: Screening Substances for Human Toxicity Potential, Elucidating Subcellular Mechanisms and In Vivo Use as Translational Safety Biomarkers
Peter J. O'Brien
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2014)
Toward predictive models for drug-induced liver injury in humans: are we there yet?
Minjun Chen et al.
BIOMARKERS IN MEDICINE (2014)
Zebrafish as model organisms for studying drug-induced liver injury
A. D. Bastiaan Vliegenthart et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Mechanistic biomarkers in acetaminophen-induced hepatotoxicity and acute liver failure: from preclinical models to patients
Mitchell R. McGill et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2014)
Drug-induced liver injury: what was new in 2013?
Walid M. Chalhoub et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2014)
Human Drug-Induced Liver Injury Severity Is Highly Associated With Dual Inhibition of Liver Mitochondrial Function and Bile Salt Export Pump
Michael D. Aleo et al.
HEPATOLOGY (2014)
Drug-Induced Liver Injury
Michael D. Leise et al.
MAYO CLINIC PROCEEDINGS (2014)
Drug-Induced Endoplasmic Reticulum and Oxidative Stress Responses Independently Sensitize Toward TNFα-Mediated Hepatotoxicity
Lisa Fredriksson et al.
TOXICOLOGICAL SCIENCES (2014)
Predicting idiosyncratic drug-induced liver injury - some recent advances
Minjun Chen et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2014)
Risk Factors for Development of Cholestatic Drug-Induced Liver Injury: Inhibition of Hepatic Basolateral Bile Acid Transporters Multidrug Resistance-Associated Proteins 3 and 4
Kathleen Koeck et al.
DRUG METABOLISM AND DISPOSITION (2014)
The Role of Bile Salt Export Pump Gene Repression in Drug-Induced Cholestatic Liver Toxicity
Brandy Garzel et al.
DRUG METABOLISM AND DISPOSITION (2014)
Multi-cell type human liver microtissues for hepatotoxicity testing
S. Messner et al.
ARCHIVES OF TOXICOLOGY (2013)
Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME
Patricio Godoy et al.
ARCHIVES OF TOXICOLOGY (2013)
Mechanisms of Drug-induced Liver Injury
Liyun Yuan et al.
CLINICS IN LIVER DISEASE (2013)
Avoiding Idiosyncratic DILI: Two Is Better Than One
Neil Kaplowitz
HEPATOLOGY (2013)
High Lipophilicity and High Daily Dose of Oral Medications Are Associated With Significant Risk for Drug-Induced Liver Injury
Minjun Chen et al.
HEPATOLOGY (2013)
Use of Micropatterned Cocultures to Detect Compounds That Cause Drug-Induced Liver Injury in Humans
Salman R. Khetani et al.
TOXICOLOGICAL SCIENCES (2013)
A Multifactorial Approach to Hepatobiliary Transporter Assessment Enables Improved Therapeutic Compound Development
Ryan E. Morgan et al.
TOXICOLOGICAL SCIENCES (2013)
A long-term three dimensional liver co-culture system for improved prediction of clinically relevant drug-induced hepatotoxicity
Radina Kostadinova et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2013)
Preclinical Strategy to Reduce Clinical Hepatotoxicity Using in Vitro Bioactivation Data for >200 Compounds
Melanie Z. Sakatis et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2012)
In Vitro Approach to Assess the Potential for Risk of Idiosyncratic Adverse Reactions Caused by Candidate Drugs
Richard A. Thompson et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2012)
In Vitro Inhibition of the Bile Salt Export Pump Correlates with Risk of Cholestatic Drug-Induced Liver Injury in Humans
Sarah Dawson et al.
DRUG METABOLISM AND DISPOSITION (2012)
Ambrisentan
James E. Frampton
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2011)
Structural Alert/Reactive Metabolite Concept as Applied in Medicinal Chemistry to Mitigate the Risk of Idiosyncratic Drug Toxicity: A Perspective Based on the Critical Examination of Trends in the Top 200 Drugs Marketed in the United States
Antonia F. Stepan et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2011)
FDA-approved drug labeling for the study of drug-induced liver injury
Minjun Chen et al.
DRUG DISCOVERY TODAY (2011)
Huh-7 or HepG2 cells: which is the better model for studying human apolipoprotein-B100 assembly and secretion?
Steven J. R. Meex et al.
JOURNAL OF LIPID RESEARCH (2011)
Translating Clinical Findings into Knowledge in Drug Safety Evaluation - Drug Induced Liver Injury Prediction System (DILIps)
Zhichao Liu et al.
PLOS COMPUTATIONAL BIOLOGY (2011)
Sandwich-cultured hepatocytes: an in vitro model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity
Brandon Swift et al.
DRUG METABOLISM REVIEWS (2010)
Intrinsic versus Idiosyncratic Drug-Induced Hepatotoxicity-Two Villains or One?
Robert A. Roth et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Idiosyncratic Drug-Induced Liver Injury and the Role of Inflammatory Stress with an Emphasis on an Animal Model of Trovafloxacin Hepatotoxicity
Patrick J. Shaw et al.
TOXICOLOGICAL SCIENCES (2010)
Cellular imaging predictions of clinical drug-induced liver injury
Jinghai J. Xu et al.
TOXICOLOGICAL SCIENCES (2008)
Circumventing the crabtree effect: Replacing media glucose with galactose increases susceptibility of HepG2 cells to mitochondrial toxicants
Lisa D. Marroquin et al.
TOXICOLOGICAL SCIENCES (2007)
Mitochondrial abnonnalities - A link to idiosyncratic drug hepatotoxicity?
Urs A. Boelsterli et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2007)
Do preclinical testing strategies help predict human hepatotoxic potentials?
TS Peters
TOXICOLOGIC PATHOLOGY (2005)
New technologies and screening strategies for hepatotoxicity: Use of in vitro models
DM Dambach et al.
TOXICOLOGIC PATHOLOGY (2005)
Troglitazone-induced intrahepatic cholestasis by an interference with the hepatobiliary export of bile acids in male and female rats. Correlation with the gender difference in troglitazone sulfate formation and the inhibition of the canalicular bile salt export pump (Bsep) by troglitazone and troglitazone sulfate
C Funk et al.
TOXICOLOGY (2001)
The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: A potential mechanism for hepatic adverse reactions
K Fattinger et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2001)
Concordance of the toxicity of pharmaceuticals in humans and in animals
H Olson et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2000)
分享论文
